Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > IMRX Immuneering > Company Profile
IMRX Immuneering
5.670
-0.440-7.20%
Symbol
IMRX
Company Name
Immuneering
Listing Date
07/30/2021
Establishment Date
2008
CEO
Dr. Benjamin J. Zeskind, PhD
Market
NASDAQ
Employees
64
Securities Type
DR
Fiscal Year Ends
12-31
Address
245 Main Street,2nd floor
City
Cambridge
Province
Massachusetts
Country
United States of America
Zip code
02142
Phone
1-617-500-8080
Profile
Immuneering Corp. engages in the development of new medicines which are unlikely to be found by traditional drug discovery methods. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.
Company Overview
Immuneering Corp. engages in the development of new medicines which are unlikely to be found by traditional drug discovery methods. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.
CEO: Dr. Benjamin J. Zeskind, PhD
Market: NASDAQ
Listing Date: 07/30/2021
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist